Adverse reaction to injection of neurotoxin (Q44201): Difference between revisions

← Older edit

@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/768286286
@@ Property / Canonical URI: https://id.who.int/icd/entity/768286286 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:EL73.2
@@ Property / CURIE: CID11:EL73.2 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-EL73.2
@@ Property / Canary Token: dki-india-EL73.2 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+L98.9
@@ Property / Linked ICD 10: L98.9 / rank @@
+Normal rank

Latest revision as of 11:34, 13 August 2026

Adverse event resulting from use of neurotoxins, especially botulinum toxin, into the skin. This is most commonly administered for aesthetic reasons. Recognised problems include ptosis, diplopia and hypersensitivity to the toxin. Details of the reaction should be coded separately.

Language	Label	Description	Also known as
default for all languages	EL73.2
English	Adverse reaction to injection of neurotoxin	Adverse event resulting from use of neurotoxins, especially botulinum toxin, into the skin. This is most commonly administered for aesthetic reasons. Recognised problems include ptosis, diplopia and hypersensitivity to the toxin. Details of the reaction should be coded separately.